1,361
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Circular RNA_0078767 upregulates Kruppel-like factor 9 expression by targeting microRNA-889, thereby inhibiting the progression of osteosarcoma

, ORCID Icon &
Pages 14313-14328 | Received 15 Feb 2022, Accepted 26 May 2022, Published online: 26 Jun 2022

References

  • Simpson E, Brown HL. Understanding osteosarcomas. JAAPA. 2018;31(8):15–19.
  • Biazzo A, De Paolis M. Multidisciplinary approach to osteosarcoma. Acta Orthop Belg. 2016;82(4):690–698.
  • Harrison DJ, Geller DS, Gill JD, et al. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 2018;18(1):39–50.
  • Xie L, Pan Z. Circular RNA circ_0000467 regulates colorectal cancer development via miR-382-5p/EN2 axis. Bioengineered. 2021 Dec;12(1):886–897.
  • Wang Y, Liu J, Ma J, et al. Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer. 2019 Jul 5;18(1):116.
  • Yang F, Hu A, Li D, et al. Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation. Mol Cancer. 2019 Nov 13;18(1):158.
  • Luo GC, Chen L, Fang J, et al. Hsa_circ_0030586 promotes epithelial-mesenchymal transition in prostate cancer via PI3K-AKT signaling. Bioengineered. 2021 Dec;12(2):11089–11107.
  • Jin J, Chen A, Qiu W, et al. Dysregulated circRNA_100876 suppresses proliferation of osteosarcoma cancer cells by targeting microRNA-136. J Cell Biochem. 2019 Sep;120(9):15678–15687.
  • Wu Y, Xie Z, Chen J, et al. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression. Mol Cancer. 2019 Apr 2;18(1):73.
  • Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an overview. Methods Mol Biol. 2017;1509:1–10.
  • Mohr AM, Mott JL. Overview of microRNA biology. Semin Liver Dis. 2015;35(1):3–11.
  • Zhang J, Yan YG, Wang C, et al. MicroRNAs in osteosarcoma. Clin Chim Acta. 2015;444:9–17.
  • Gong N, Gong M. MiRNA-221 from tissue may predict the prognosis of patients with osteosarcoma. Medicine (Baltimore). 2018;97(29):e11100.
  • Ge D, Chen H, Zheng S, et al. Hsa-miR-889-3p promotes the proliferation of osteosarcoma through inhibiting myeloid cell nuclear differentiation antigen expression. Biomed Pharmacother. 2019 Jun;114:108819.
  • Bagati A, Moparthy S, Fink EE, et al. KLF9-dependent ROS regulate melanoma progression in stage-specific manner. Oncogene. 2019 May;38(19):3585–3597.
  • Liu Y, Han K, Cao Y, et al. KLF9 regulates miR-338-3p/NRCAM axis to block the progression of osteosarcoma cells. J Cancer. 2022 Mar 28;13(6):2029–2039.
  • Han X, Tang Y, Dai Y, et al. MiR-889 promotes cell growth in human non-small cell lung cancer by regulating KLF9. Gene. 2019 May 30;699:94–101.
  • Jin Y, Xu L, Zhao B, et al. Tumour-suppressing functions of the lncRNA MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells. Cell Cycle. 2022 May;21(9):908–920.
  • Lu Z, Wang C, Lv X, et al. Hsa_circ_0010220 regulates miR-198/syntaxin 6 axis to promote osteosarcoma progression. J Bone Oncol. 2021 Apr 22; 28:100360
  • Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108.
  • Wang H, Wang H, Cui W, et al. Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma. Diagn Pathol. 2021 Jun 11;16(1):51.
  • Liu F, Zhang X, Wu F, et al. Hsa_circ_0088212-mediated miR-520 h/APOA1 axis inhibits osteosarcoma progression. Transl Oncol. 2021 Dec;14(12):101219.
  • Nie C, Han J, Bi W, et al. Circular RNA circ_0000644 promotes papillary thyroid cancer progression via sponging miR-1205 and regulating E2F3 expression. Cell Cycle. 2022 Jan;21(2):126–139.
  • Li S, Peng D, Yin ZQ, et al. Effect of DEC1 on the proliferation, adhesion, invasion and epithelial-mesenchymal transition of osteosarcoma cells. Exp Ther Med. 2020 Mar;19(3):2360–2366.
  • Xu L, Shi L, Qiu S, et al. Design, synthesis, and evaluation of cyanopyridines as anti-colorectal cancer agents via inhibiting STAT3 pathway. Drug Des Devel Ther. 2019 Sep 24;13:3369–3381.
  • Yu X, Gao X, Mao X, et al. Knockdown of FOXO6 inhibits glycolysis and reduces cell resistance to paclitaxel in HCC cells via PI3K/Akt signaling pathway. Onco Targets Ther. 2020 Feb 19;13:1545–1556.
  • Chen X, Zhang Y, Zhang S, et al. Oleanolic acid inhibits osteosarcoma cell proliferation and invasion by suppressing the SOX9/Wnt1 signaling pathway. Exp Ther Med. 2021 May;21(5):443.
  • Gong Z, Chen X, Zhang Y, et al. LncRNA GATA6-AS1 inhibits the progression of non-small cell lung cancer via repressing microRNA-543 to up-regulating RKIP. Cancer Manag Res. 2020 Sep 29;12:9327–9338.
  • Wu Y, Shen Q, Chen X, et al. miR-1301-3p promotes the proliferation and migration of lung cancer cells via direct repression of polymerase I and transcript release factor. Oncol Lett. 2020 Dec;20(6):286.
  • Zhang Y, Zhang Z, Yi Y, et al. CircNOL10 acts as a sponge of miR-135a/b-5p in suppressing colorectal cancer progression via regulating KLF9. Onco Targets Ther. 2020 Jun 8;13:5165–5176.
  • Jiang LP, Wang SR, Chung HK, et al. miR-222 represses expression of zipcode binding protein-1 and phospholipase C-γ1 in intestinal epithelial cells. Am J Physiol Cell Physiol. 2019 Mar 1;316(3):C415–C423.
  • Luo Z, Rong Z, Zhang J, et al. Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression. Mol Cancer. 2020 May 9;19(1):86.
  • Zhang HD, Jiang LH, Sun DW, et al. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25(1):1–7.
  • Zhang YQ, Shao CC, Li CT, et al. Research progress of circRNA and its significance in forensic science. Fa Yi Xue Za Zhi. 2016;32(2):131–133.
  • Ng WL, Mohd Mohidin TB, Shukla K. Functional role of circular RNAs in cancer development and progression. RNA Biol. 2018;15(8):995–1005.
  • Wang Y, Mo Y, Gong Z, et al. Circular RNAs in human cancer. Mol Cancer. 2017;16(1):25.
  • Bach DH, Lee SK, Sood AK. Circular RNAs in cancer. Mol Ther Nucleic Acids. 2019;16:118–129.
  • Xiao-Long M, Kun-Peng Z, Chun-Lin Z. Circular RNA circ_HIPK3 is down-regulated and suppresses cell proliferation, migration and invasion in osteosarcoma. J Cancer. 2018;9(10):1856–1862.
  • Long Z, Gong F, Li Y, et al. Circ_0000285 regulates proliferation, migration, invasion and apoptosis of osteosarcoma by miR-409-3p/IGFBP3 axis. Cancer Cell Int. 2020 Oct 6;20:481.
  • Chen T, Yang Z, Liu C, et al. Circ_0078767 suppresses non-small-cell lung cancer by protecting RASSF1A expression via sponging miR-330-3p. Cell Prolif. 2019;52(2):e12548.
  • Deb B, Uddin A, Chakraborty S. miRNAs and ovarian cancer: an overview. J Cell Physiol. 2018;233(5):3846–3854.
  • Iqbal MA, Arora S, Prakasam G, et al. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Aspects Med. 2019;70:3–20.
  • Li D, Zhang J, Li J. Role of miRNA sponges in hepatocellular carcinoma. Clin Chim Acta. 2020;500:10–19.
  • Otoukesh B, Abbasi M, Gorgani HO, et al. MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma. Cancer Cell Int. 2020;20:254.
  • Chen G, Zhou H. MiRNA-708/CUL4B axis contributes into cell proliferation and apoptosis of osteosarcoma. Eur Rev Med Pharmacol Sci. 2018;22(17):5452–5459.
  • Xu N, Yang W, Liu Y, et al. MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression. Environ Sci Pollut Res Int. 2018;25(12):12064–12071.
  • Xu Y, He J, Wang Y, et al. miR-889 promotes proliferation of esophageal squamous cell carcinomas through DAB2IP. FEBS Lett. 2015;589(10):1127–1135.
  • Xiao Y, Li ZH, Bi YH. MicroRNA-889 promotes cell proliferation in colorectal cancer by targeting DAB2IP. Eur Rev Med Pharmacol Sci. 2019;23(8):3326–3334.
  • Jin Y, Li L, Zhu T, et al. Circular RNA circ_0102049 promotes cell progression as ceRNA to target MDM2 via sponging miR-1304-5p in osteosarcoma. Pathol Res Pract. 2019;215(12):152688.
  • Tung B, Ma D, Wang S, et al. Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells. BMC Cancer. 2018;18(1):1025.
  • Ilsley MD, Huang S, Magor GW, et al. Corrupted DNA-binding specificity and ectopic transcription underpin dominant neomorphic mutations in KLF/SP transcription factors. BMC Genomics. 2019;20(1):417.
  • Kong YJ, Tan XX, Zhang Y, et al. MiR-141 promotes cell proliferation and invasion in non-small cell lung cancer by targeting KLF9. Eur Rev Med Pharmacol Sci. 2019;23(23):10370–10378.
  • Bai XY, Li S, Wang M, et al. Krüppel-like factor 9 down-regulates matrix metalloproteinase 9 transcription and suppresses human breast cancer invasion. Cancer Lett. 2018;412:224–235.
  • Brown AR, Simmen RC, Raj VR, et al. Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling. Carcinogenesis. 2015;36(9):946–955.
  • Jin Y, Yang L, Li X. MicroRNA-652 promotes cell proliferation and osteosarcoma invasion by directly targeting KLF9. Exp Ther Med. 2020;20(4):2953–2960.
  • Peng N, Miao Z, Wang L, et al. MiR-378 promotes the cell proliferation of osteosarcoma through down-regulating the expression of Kruppel-like factor 9. Biochem Cell Biol. 2018;96(5):515–521.